Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer
Giovanni Selvaggi, Silvia Novello, Valter Torri et al. · Annals of Oncology · 2003
Cited by 292 works. doi:10.1093/annonc/mdh011 Open-access PDF
Authors
- Giovanni Selvaggi
- Silvia Novello
- Valter Torri
- E Leonardo
- Paolo De Giuli
- Piero Borasio
- C Mossetti
- Francesco Ardissone
- Paolo Olivo Lausi
- Giorgio V. Scagliotti
References
- Regression Models and Life-Tables
- Signal transduction by receptors with tyrosine kinase activity
- Revisions in the International System for Staging Lung Cancer
- Cancer Statistics, 2002
- Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
- Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.
- EGFR and cancer prognosis
- Histological Typing of Lung Tumours
- A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.
- The EGF receptor family as targets for cancer therapy